Benefits of Exercise Therapy in Nonalcoholic Fatty Liver Disease (NAFLD)
Exercise therapy plays a crucial role in managing nonalcoholic fatty liver disease (NAFLD) by improving hepatic aminotransferases and reducing steatosis. Lifestyle modifications, including increased physical activity, are essential in the treatment of NAFLD. This includes aerobic exercise, resistanc
0 views • 32 slides
Prediction of Liver Fibrosis in NAFLD Patients: Impact of CAP Values
Steatosis has emerged as a significant diagnosis with NAFLD becoming a common cause for hepatologic evaluation. Liver stiffness measurement (LSM) using transient elastography is vital for assessing fibrosis severity in NAFLD patients. However, the accuracy of LSM can be influenced by obesity and sev
0 views • 35 slides
Evaluation Methods for Liver Steatosis in Obese Children
This study examines the assessment of liver steatosis in obese children using MRI, ultrasound, and biology techniques, evaluating methods such as attenuation coefficient and proton density fat fraction. The aim is to develop noninvasive biomarkers and validate existing scores for predicting NAFLD. P
0 views • 22 slides
Understanding Drug-Induced Liver Injury (DILI)
Drug-induced liver injury (DILI) can present as cholestasis, hepatocyte necrosis, steatosis, vascular damage, and hepatic fibrosis. Various drugs like antibiotics, NSAIDs, recreational drugs, and herbal remedies can cause liver damage. Recognizing DILI is crucial in patients with liver dysfunction o
0 views • 9 slides